세계의 이식형 약물전달 기기 시장 - 규모, 점유율, 동향 분석 보고서 : 제품별, 유형별, 기술별, 용도별, 지역별, 부문별 예측(2024-2030년)

Implantable Drug Delivery Devices Market Growth & Trends:

The global implantable drug delivery devices market size is expected to reach USD 47.01 billion by 2030, registering to grow at a CAGR of 8.2% from 2024 to 2030 according to a new report by Grand View Research, Inc. The growing incidence of chronic diseases, coupled with rising demand for minimally invasive treatment options, is driving the market for implantable drug delivery devices.

Recent advancements in medication administration technologies are expected to fuel market growth over the forecast period. An increase in the adoption of micro-scale implantable devices is one of the key factors fueling growth. These products find application in monitoring improvement in body functions, imaging, and medication administration. They facilitate localized treatment with controlled drug administration and enable targeted delivery of therapeutics to tissues.

These devices help overcome limitations of intravenous, oral, and topical administration routes, thus broadening the growth prospects of the market. In addition, the advent of biodegradable implants enables the targeted delivery of chemotherapeutics to tumor cells without damaging normal cells. Drug releasing implants are also helpful in the treatment of inoperable tumors such as that of the liver, brain, and lungs, due to their location and size. These devices help in reducing tumor size, which enables the surgical removal of tumors. The aforementioned benefits of these devices are expected to impel their adoption over the forecast period.

Manufacturers are focused on developing novel drug delivery devices to gain maximum market share, which has resulted in the launch of various technologically advanced products in the market. For instance, in February 2017, Delpor, Inc., a biotechnology company in U.S., announced the launch of an implantable device for the long-term delivery of therapeutics.

Implantable Drug Delivery Devices Market Report Highlights:

• By product, drug-eluting stents held a dominant share in the market in 2023, owing to their growing adoption in hormone regulation, contraception, pain management, and cancer therapy. Bio-absorbable stents, on the other hand, are anticipated to grow at a lucrative rate owing to the increase in incidence of peripheral and coronary artery diseases
• On the basis of type, the non-biodegradable segment held the largest share in 2023, as a consequence of easy availability of these products and their established efficacy
• Diffusion held a dominant share in the market on the basis of technology, owing to a significant increase in adoption as it offers better patient outcomes and acceptability
• Autoimmune diseases, on the other hand, are expected to exhibit the fastest CAGR owing to rising prevalence of multiple sclerosis and rheumatoid arthritis
• While North America held a substantial share in 2023 owing to the rising prevalence of chronic diseases, unhealthy lifestyles, and high-stress levels among the population, Asia Pacific is anticipated to achieve significant CAGR through 2025. This is owing to improving healthcare systems, rising healthcare expenditure, and growing awareness.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market
• 1.2. Segmentation and Scope
• 1.3. Market Definitions
• 1.4. Research Methodology
  • 1.4.1. Information Procurement
  • 1.4.2. Information or Data Analysis
  • 1.4.3. Market Formulation & Data Visualization
  • 1.4.4. Data Validation & Publishing
• 1.5. Research Scope and Assumptions
  • 1.5.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Implantable Drug Delivery Devices Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Implantable Drug Delivery Devices Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Implantable Drug Delivery Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Implantable Drug Delivery Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
• 4.3. Contraceptive Implants
  • 4.3.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Spinal Implants
  • 4.4.1. Spinal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Brachytherapy Seeds
  • 4.5.1. Brachytherapy Seeds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Drug Eluting Stents
  • 4.6.1. Drug Eluting Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Bioabsorbable Stents
  • 4.7.1. Bioabsorbable Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Intraocular Implants
  • 4.8.1. Intraocular Implants Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
• 4.9. Infusion Pumps
  • 4.9.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
• 4.10. Others
  • 4.10.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 5. Implantable Drug Delivery Devices Market: Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Implantable Drug Delivery Devices Market: Type Movement Analysis, 2023 & 2030 (USD Million)
• 5.3. Biodegradable
  • 5.3.1. Biodegradable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Non-biodegradable
  • 5.4.1. Non-biodegradable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Implantable Drug Delivery Devices Market: Technology Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Implantable Drug Delivery Devices Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
• 6.3. Diffusion
  • 6.3.1. Diffusion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Osmotic
  • 6.4.1. Osmotic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Magnetic
  • 6.5.1. Magnetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Implantable Drug Delivery Devices Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Implantable Drug Delivery Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
• 7.3. Contraception
  • 7.3.1. Contraception Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Ophthalmology
  • 7.4.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Cardiovascular
  • 7.5.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Diabetes
  • 7.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Oncology
  • 7.7.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Autoimmune Diseases
  • 7.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Others
  • 7.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Implantable Drug Delivery Devices Market: Regional Estimates & Trend Analysis

• 8.1. Implantable Drug Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
• 8.2. North America
  • 8.2.1. North America Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. U.S. Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.2.3. Canada
    • 8.2.3.1. Canada Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.2.4. Mexico
    • 8.2.4.1. Mexico Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.3. Europe
  • 8.3.1. Europe Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.K.
    • 8.3.2.1. U.K. Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Germany
    • 8.3.3.1. Germany Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. France
    • 8.3.4.1. France Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. China
    • 8.4.2.1. China Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Japan
    • 8.4.3.1. Japan Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. India
    • 8.4.4.1. India Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. South Korea
    • 8.4.5.1. South Korea Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Australia
    • 8.4.6.1. Australia Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Latin America
  • 8.5.1. Latin America Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Brazil Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Middle East and Africa
  • 8.6.1. Middle East and Africa Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Saudi Arabia
    • 8.6.2.1. Saudi Arabia Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. UAE
    • 8.6.3.1. UAE Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. South Africa
    • 8.6.4.1. South Africa Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Heat Map Analysis
• 9.4. Company Profiles
  • 9.4.1. Medtronic
    • 9.4.1.1. Participant's Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Recent Developments/ Strategic Initiatives
  • 9.4.2. Boston Scientific Corporation
    • 9.4.2.1. Participant's Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Recent Developments/ Strategic Initiatives
  • 9.4.3. Allergan
    • 9.4.3.1. Participant's Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Recent Developments/ Strategic Initiatives
  • 9.4.4. Merck & Co., Inc.
    • 9.4.4.1. Participant's Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Recent Developments/ Strategic Initiatives
  • 9.4.5. Bausch and Lomb Incorporated
    • 9.4.5.1. Participant's Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Recent Developments/ Strategic Initiatives
  • 9.4.6. Bayer AG
    • 9.4.6.1. Participant's Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Recent Developments/ Strategic Initiatives
  • 9.4.7. Abbott
    • 9.4.7.1. Participant's Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Recent Developments/ Strategic Initiatives
  • 9.4.8. Teleflex Incorporated
    • 9.4.8.1. Participant's Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Recent Developments/ Strategic Initiatives
  • 9.4.9. Varian Medical Systems, Inc.
    • 9.4.9.1. Participant's Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Recent Developments/ Strategic Initiatives